DexCom, Inc.
DXCM
81.39+1.05 (+1.30%)Nov 12, 5:31 PM ET
Key stats
- Open
- 80.99
- Day high
- 82.51
- Day low
- 79.38
- Previous close
- 80.35
- Volume
- 4.09M
- VWAP
- 81.26
- 52-week high
- 92.59
- 52-week low
- 56.72
- Market cap
- 29.96B
- Shares out
- 372.95M
- Employees
- 11,100
- Listed
- 2005
About DexCom, Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SAN DIEGO, CA · dexcom.com
Options · expiring Nov 13
Nov 12, 4:00 PM ET- Call open interest
- 680
- Put open interest
- 337
- Put/call
- 0.50
- At-the-money IV
- 65.0%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 81 call | 1.00 | Nov 12, 12:10 PM | 53 | 13 | 65.0% |
| 79 call | 1.75 | Nov 10, 11:45 AM | 44 | 53 | 67.7% |
| 80 put | 1.05 | Nov 11, 11:58 AM | 31 | 26 | 109.9% |
| 93 call | 0.40 | Nov 2, 3:46 PM | 30 | 30 | 245.1% |
| 77 put | 1.00 | Nov 6, 3:47 PM | 23 | 37 | 166.1% |
| 70 call | 9.60 | Nov 10, 10:44 AM | 19 | 22 | — |
Quarterly results
Massive · Oct 29, 2026| Q3 2026 to Sep 30, 2026 | Q2 2026 to Jun 30, 2026 | Q1 2026 to Mar 31, 2026 | Q4 2025 to Dec 31, 2025 | |
|---|---|---|---|---|
| Revenue | $1.34B | $1.31B | $1.19B | $1.26B |
| Gross profit | $864.40M | $830.00M | $750.30M | $792.70M |
| Operating income | $327.20M | $318.30M | $255.30M | $323.00M |
| Net income | $275.10M | $249.10M | $199.50M | $267.30M |
| Diluted EPS | 0.72 | 0.64 | 0.51 | 0.67 |
| Operating cash flow | $325.60M | $269.20M | $525.60M | $294.00M |
| Assets | $6.24B | $6.46B | $6.63B | $6.34B |
| Liabilities | $3.70B | $3.83B | $3.68B | $3.59B |
| Equity | $2.54B | $2.62B | $2.96B | $2.75B |
Technicals
Massive · Nov 12, 2026- 50-day average84.43
- 200-day average75.03
- RSI (14 days)47.3
Short interest
Massive · Oct 30, 2026- Oct 30, 202615.93M shares · 2.8 days to cover
- Oct 15, 202615.69M shares · 4.8 days to cover
- Sep 30, 202614.02M shares · 3.2 days to cover
- Sep 15, 202617.26M shares · 5.0 days to cover
Splits
Massive · Jun 13, 2022- Jun 13, 20224-for-1
Related companies
MassiveNews coverage
No stories about DexCom, Inc. right now.